Author Question: If a pharmaceutical company wished to design a drug to maintain low blood sugar (Read 612 times)

TI

  • Sr. Member
  • ****
  • Posts: 434
If a pharmaceutical company wished to design a drug to maintain low blood sugar levels, one approach might be to design a compound
A) that activates epinephrine receptors.
B) that increases cAMP production in liver cells.
C) to block G protein activity in liver cells.
D) that increases phosphorylase activity.
E) that keeps sugar molecules from crossing the plasma membrane of liver cells.



coco

  • Hero Member
  • *****
  • Posts: 739
In class, we found it was C. Good luck with the rest.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

TI

  • Sr. Member
  • ****
  • Posts: 434

 

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

Throughout history, plants containing cardiac steroids have been used as heart drugs and as poisons (e.g., in arrows used in combat), emetics, and diuretics.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

For a complete list of videos, visit our video library